These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 2128969

  • 1. A collaborative study to establish a standard for high molecular weight urinary-type plasminogen activator (HMW/u-PA).
    Gaffney PJ, Heath AB.
    Thromb Haemost; 1990 Nov 30; 64(3):398-401. PubMed ID: 2128969
    [Abstract] [Full Text] [Related]

  • 2. A collaborative study to establish the 2nd international standard for tissue plasminogen activator (t-PA).
    Gaffney PJ, Curtis AD.
    Thromb Haemost; 1987 Dec 18; 58(4):1085-7. PubMed ID: 3127919
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA, Groeneveld E, Rijken DC.
    Thromb Haemost; 1993 Sep 01; 70(3):481-5. PubMed ID: 8259553
    [Abstract] [Full Text] [Related]

  • 4. A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA).
    Gaffney PJ, Curtis AD.
    Thromb Haemost; 1985 Feb 18; 53(1):134-6. PubMed ID: 4039472
    [Abstract] [Full Text] [Related]

  • 5. The international standard for plasminogen activator inhibitor-1 (PAI-1) activity.
    Gaffney PJ, Edgell TA.
    Thromb Haemost; 1996 Jul 18; 76(1):80-3. PubMed ID: 8819256
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA).
    Creighton-Kempsford LJ, Pring JB, Gaffney PJ.
    Blood Coagul Fibrinolysis; 1992 Aug 18; 3(4):481-3. PubMed ID: 1420825
    [Abstract] [Full Text] [Related]

  • 7. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, De Cock F, Collen D.
    Thromb Haemost; 1988 Oct 31; 60(2):247-50. PubMed ID: 3146141
    [Abstract] [Full Text] [Related]

  • 8. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ, Dooijewaard G, Turion PN.
    Thromb Haemost; 1991 Feb 12; 65(2):144-8. PubMed ID: 1905069
    [Abstract] [Full Text] [Related]

  • 9. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM, Gamba C, Kordich LC.
    Thromb Res; 2007 Feb 12; 120(5):745-52. PubMed ID: 17270255
    [Abstract] [Full Text] [Related]

  • 10. Influence of low- and high-molecular-weight plasminogen activators on the onset of labor and on the hemostatic system.
    Moriyama T, Suzuki S, Matsuno K, Okada K, Matsuo O.
    Semin Thromb Hemost; 2002 Dec 12; 28(6):529-32. PubMed ID: 12536345
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. International collaborative study on the assay of commerically available high and low molecular weight urokinases.
    Gaffney PJ, Tydeman MS, Kirkwood TB, Aronson D, Murano G.
    Thromb Haemost; 1981 Feb 23; 45(1):34-7. PubMed ID: 7018003
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro.
    Lourenço DM, Dosne AM, Kher A, Samama M.
    Thromb Haemost; 1989 Nov 24; 62(3):923-6. PubMed ID: 2556812
    [Abstract] [Full Text] [Related]

  • 15. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y, Scully MF, Ellis V, Kakkar VV.
    Thromb Haemost; 1989 Jun 30; 61(3):502-6. PubMed ID: 2508259
    [Abstract] [Full Text] [Related]

  • 16. Possible use of monoclonal antibodies to standardize the production and use of human urokinase.
    Harris WJ, Weston J, Gilmour J, Hart H.
    Dev Biol Stand; 1984 Jun 30; 57():349-54. PubMed ID: 6543201
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [High Molecular Weight Urokinase Reference Standard (Control 901) of National Institute of Health Sciences].
    Okada S, Yomota C, Murai M, Tanimoto T, Kimura T.
    Eisei Shikenjo Hokoku; 1993 Jun 30; (111):133-6. PubMed ID: 7920555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.